Group One Trading’s Indaptus Therapeutics INDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Hold |
0
| – | -$4 | – | 8254 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7463 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 7156 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6531 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6594 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6888 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 7256 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 7523 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 7559 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7086 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 7117 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 7831 |
|
|
2022
Q2 | – | Hold |
0
| – | – | – | 8126 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 8319 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 8486 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 8444 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 8328 |
|
|
2021
Q1 | – | Sell |
-9
| Closed | -$3K | – | 7769 |
|
|
2020
Q4 | $3K | Sell |
9
-8
| -47% | -$3.49K | ﹤0.01% | 6161 |
|
|
2020
Q3 | $9K | Buy |
17
+10
| +143% | +$7.35K | ﹤0.01% | 5458 |
|
|
2020
Q2 | $5K | Buy |
+7
| New | +$4.33K | ﹤0.01% | 5360 |
|
|
2020
Q1 | – | Sell |
-9
| Closed | -$6.8K | – | 5486 |
|
|
2019
Q4 | $10K | Sell |
9
-8
| -47% | -$11K | ﹤0.01% | 4597 |
|
|
2019
Q3 | $28K | Buy |
17
+10
| +143% | +$29.8K | ﹤0.01% | 4230 |
|
|
2019
Q2 | $68K | Hold |
7
| – | – | ﹤0.01% | 3604 |
|
|
2019
Q1 | $120K | Buy |
7
+4
| +133% | +$70.1K | ﹤0.01% | 3052 |
|
|
2018
Q4 | $51K | Buy |
+3
| New | +$40.9K | ﹤0.01% | 3548 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 5376 |
|
Other funds holding INDP
SS
TRCT
Group One Trading's INDP Position: Q2 2025 in Review
Group One Trading held its Indaptus Therapeutics (INDP) position steady in Q2 2025 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #8254.
Group One Trading first reported a position in INDP in Q4 2018 and has held it in 8 quarters since. The position peaked at $120K in Q1 2019. 5 funds tracked by Wall St. Rank hold INDP as of Q2 2025.
- Group One Trading held 0 shares of Indaptus Therapeutics worth $0 as of Q2 2025.
- Group One Trading left its Indaptus Therapeutics share count unchanged in Q2 2025.
- Indaptus Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q2 2025, its #8254 holding.
- Group One Trading first reported a position in Indaptus Therapeutics in Q4 2018 and has held it in 8 quarters since.
- Group One Trading's Indaptus Therapeutics position peaked at $120K in Q1 2019.
- 5 funds tracked by Wall St. Rank held Indaptus Therapeutics as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.